Your browser doesn't support javascript.
Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties.
Saito, Shiki; Ohashi, Hirofumi; Nakamura, Kou; Otagaki, Junichiro; Nishioka, Kazane; Nishiuchi, Kota; Nakamura, Ayaka; Tsurukawa, Yukine; Shibasaki, Hisanobu; Murakami, Hironobu; Nagane, Masaki; Okada, Maiko; Kuramochi, Kouji; Watashi, Koichi; Kamisuki, Shinji.
  • Saito S; School of Veterinary Medicine, Azabu University.
  • Ohashi H; Department of Applied Biological Science, Tokyo University of Science.
  • Nakamura K; Department of Virology II, National Institute of Infectious Diseases.
  • Otagaki J; Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases.
  • Nishioka K; School of Veterinary Medicine, Azabu University.
  • Nishiuchi K; School of Veterinary Medicine, Azabu University.
  • Nakamura A; Department of Applied Biological Science, Tokyo University of Science.
  • Tsurukawa Y; Department of Virology II, National Institute of Infectious Diseases.
  • Shibasaki H; Department of Applied Biological Science, Tokyo University of Science.
  • Murakami H; School of Veterinary Medicine, Azabu University.
  • Nagane M; School of Veterinary Medicine, Azabu University.
  • Okada M; School of Veterinary Medicine, Azabu University.
  • Kuramochi K; School of Veterinary Medicine, Azabu University.
  • Watashi K; Center for Human and Animal Symbiosis Science, Azabu University.
  • Kamisuki S; School of Veterinary Medicine, Azabu University.
Chem Pharm Bull (Tokyo) ; 70(10): 679-683, 2022.
Article in English | MEDLINE | ID: covidwho-2054201
ABSTRACT
The liver X receptor is a nuclear hormone receptor that regulates lipid metabolism. Previously, we had demonstrated the antiviral properties of a liver X receptor antagonist associated with the hepatitis C virus and severe acute respiratory syndrome coronavirus 2. In this study, we screened a chemical library and identified two potential liver X receptor antagonists. Spectroscopic analysis revealed that the structures of both antagonists (compounds 1 and 2) were cyclic dimer and trimer of esters, respectively, that consisted of phthalate and 1,6-hexane diol. This study is the first to report the structure of the cyclic trimer of phthalate ester. Further experiments revealed that the compounds were impurities of solvents used for purification, although their source could not be traced. Both phthalate esters exhibited anti-hepatitis C virus activity, whereas the cyclic dimer showed anti-severe acute respiratory syndrome coronavirus 2 activity. Cyclic phthalate derivatives may constitute a novel class of liver X receptor antagonists and broad-spectrum antivirals.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Esters / COVID-19 Limits: Humans Language: English Journal: Chem Pharm Bull (Tokyo) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Esters / COVID-19 Limits: Humans Language: English Journal: Chem Pharm Bull (Tokyo) Year: 2022 Document Type: Article